Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2009-05-14

Original market date: See footnote 1

2009-05-14

Product name:

GRANISETRON HYDROCHLORIDE INJECTION

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02322765

Product Monograph/Veterinary Labelling:

Date: 2013-10-29 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

OMEGA LABORATORIES LTD
11177 Hamon
Montreal
Quebec
Canada  H3M 3E4

Class: 

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

56:22.20   5-HT3 RECEPTOR ANTAGONISTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

A04AA02  GRANISETRON

Active ingredient group (AIG) number:See footnote 5

0123183001

List of active ingredient(s)
Active ingredient(s) Strength
GRANISETRON (GRANISETRON HYDROCHLORIDE) 1 MG / ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: